Cell Uptake and Validation of Novel PECs for Biomedical Applications
about
Coupled delivery of imatinib mesylate and doxorubicin with nanoscaled polymeric vectors for a sustained downregulation of BCR-ABL in chronic myeloid leukemia.Uptake of imatinib-loaded polyelectrolyte complexes by BCR-ABL(+) cells: a long-acting drug-delivery strategy for targeting oncoprotein activity.mRNA delivery using non-viral PCL nanoparticles.
P2860
Cell Uptake and Validation of Novel PECs for Biomedical Applications
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@ast
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@en
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@nl
type
label
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@ast
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@en
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@nl
prefLabel
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@ast
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@en
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@nl
P2093
P2860
P356
P1476
Cell Uptake and Validation of Novel PECs for Biomedical Applications
@en
P2093
Addolorata M L Coluccia
Giuseppe Gigli
Mariarosaria Musarò
Stefania D'Amone
P2860
P304
P356
10.1155/2011/203676
P577
2011-08-25T00:00:00Z